# Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

> clinical trial · VERIFIED · 2026-07-29

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Pancreatic Ductal Adenocarcinoma

- Company: Novartis Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06562192

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.